Dr. Walter H Meisen currently working in Biomedical Sciences Graduate Program, The Ohio State University Wexner Medical Center, Columbus, OH, USA.Publications authored by him TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response; CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells.
|